Sands Capital: 27 Unitedhealth Group transactions (Sands Capital

27 Sands Capital Unitedhealth Group Trades

The first Unitedhealth Group trade was made in Q4 2018. Since then Sands Capital bought shares fifteen more times and sold shares on eleven occasions. The investor completely sold their stake between Q3 2024 and Q2 2025.

Avg closing price

Price range

Sold -175k shares Q2 2025

Avg closing price $380.85

Price range $274.35 - $599.47

Sold 0.5% shares (-927 shares) Q1 2025

Avg closing price $511.57

Price range $461.51 - $548.32

Sold 24.2% shares (-56.1k shares) Q4 2024

Avg closing price $567.09

Price range $485.44 - $625.35

Sold 4.7% shares (-11.5k shares) Q3 2024

Avg closing price $564.83

Price range $488.01 - $604.18

Increased shares by 55.0% (+86.4k shares) Q2 2024

Avg closing price $490.13

Price range $439.20 - $524.63

Increased shares by 1.9% (+3k shares) Q1 2024

Avg closing price $508.38

Price range $472.60 - $545.42

Increased shares by 6.1% (+8.84k shares) Q4 2023

Avg closing price $533.34

Price range $509.47 - $552.97

Increased shares by 26.6% (+30.5k shares) Q3 2023

Avg closing price $492.14

Price range $447.75 - $510.93

Sold 2.0% shares (-2.36k shares) Q2 2023

Avg closing price $488.98

Price range $458.49 - $526.23

Increased shares by 1.3% (+1.47k shares) Q1 2023

Avg closing price $482.57

Price range $460.33 - $518.64

Sold 41.0% shares (-80.2k shares) Q4 2022

Avg closing price $529.71

Price range $498.86 - $555.15

Increased shares by 12.7% (+22.1k shares) Q3 2022

Avg closing price $525.83

Price range $501.24 - $548.32

Sold 3.6% shares (-6.49k shares) Q2 2022

Avg closing price $502.19

Price range $452.06 - $546.01

Sold 17.9% shares (-39.4k shares) Q1 2022

Avg closing price $482.30

Price range $455.89 - $520.82

Sold 1.9% shares (-4.36k shares) Q4 2021

Avg closing price $452.67

Price range $387.01 - $505.58

Increased shares by 0.9% (+1.91k shares) Q3 2021

Avg closing price $414.19

Price range $390.74 - $429.71

Increased shares by 12.6% (+24.8k shares) Q2 2021

Avg closing price $398.74

Price range $364.37 - $420.89

Sold 41.1% shares (-137k shares) Q1 2021

Avg closing price $346.50

Price range $324.34 - $379.06

Increased shares by 107.4% (+173k shares) Q4 2020

Avg closing price $335.20

Price range $303.68 - $356.82

Sold 1.5% shares (-2.44k shares) Q3 2020

Avg closing price $307.17

Price range $291.16 - $323.70

News about Unitedhealth Group Inc and Sands Capital

UnitedHealth Group Incorporated (UNH) Q1 2025 Earnings Call Transcript

UnitedHealth Group Incorporated (NYSE:UNH ) Q1 2025 Results Conference Call April 17, 2025 8:45 AM ET Company Participants Andrew Witty - Chief Executive Off...

seekingalpha.com, 5 months ago

Trade Tracker: Steve Weiss buys more UnitedHealth

Steve Weiss, Founder and Managing Partner of Short Hills Capital Partners joins CNBC's “Halftime Report” to explain why he's buying UnitedHealth after famed ...

youtube.com, 7 months ago

BMO's Brian Belski weighs in on UnitedHealth

Brian Belski, BMO Capital Markets chief investment strategist, joins CNBC's 'Closing Bell' to discuss outlooks on healthcare, whether the shooting of UnitedH...

youtube.com, 9 months ago

Harbor Capital Appreciation Fund''s Strategic Moves in Q2 2024: Spotlight on UnitedHealth Group Inc

GuruFocus, about 1 year ago

Never miss a trade

早乙女迅雷

Sands Capital Unitedhealth Group Inc

Current Value of Holding

Shares

% of Portfolio

Average Buy Price

27 Sands Capital Unitedhealth Group Trades

News about Unitedhealth Group Inc and Sands Capital

UnitedHealth Group Incorporated (UNH) Q1 2025 Earnings Call Transcript

Trade Tracker: Steve Weiss buys more UnitedHealth

BMO's Brian Belski weighs in on UnitedHealth

Harbor Capital Appreciation Fund''s Strategic Moves in Q2 2024: Spotlight on UnitedHealth Group Inc

早乙女迅雷

Sands Capital Unitedhealth Group Inc

27 Sands Capital Unitedhealth Group Trades

News about Unitedhealth Group Inc and Sands Capital

UnitedHealth Group Incorporated (UNH) Q1 2025 Earnings Call Transcript

Trade Tracker: Steve Weiss buys more UnitedHealth

BMO's Brian Belski weighs in on UnitedHealth

Harbor Capital Appreciation Fund''s Strategic Moves in Q2 2024: Spotlight on UnitedHealth Group Inc

Embed chart